116 related articles for article (PubMed ID: 7117494)
1. Effects of thromboxane A2 injection on the rabbit coronary artery. I. Physiologic effects in healthy animals.
Sasagawa S; Moriya K; Sugaya Y; Mitani J; Yajima M
Exp Mol Pathol; 1982 Aug; 37(1):111-7. PubMed ID: 7117494
[No Abstract] [Full Text] [Related]
2. Effects of thromboxane A2 injection on the rabbit coronary artery. II. The production of infarcts in cholesterol-fed animals.
Numano F; Yajima M; Nishiyama K; Shimokado K; Numano F; Sasagawa S; Moriya K
Exp Mol Pathol; 1982 Aug; 37(1):118-32. PubMed ID: 6956517
[No Abstract] [Full Text] [Related]
3. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
[TBL] [Abstract][Full Text] [Related]
4. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
5. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
[TBL] [Abstract][Full Text] [Related]
6. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
[TBL] [Abstract][Full Text] [Related]
7. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
[No Abstract] [Full Text] [Related]
8. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
Svensson J
Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
[TBL] [Abstract][Full Text] [Related]
9. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
Roth DM; Lefer AM; Smith JB; Nicolaou KC
Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
Tanabe M; Terashita Z; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.
Lefer AM; Okamatsu S; Smith EF; Smith JB
Thromb Res; 1981 Aug; 23(3):265-73. PubMed ID: 6795758
[No Abstract] [Full Text] [Related]
12. Thromboxane A2: effects on airway and vascular smooth muscle.
Svenssen J; Strandberg K; Tuvemo T; Hamberg M
Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
[TBL] [Abstract][Full Text] [Related]
13. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
[No Abstract] [Full Text] [Related]
14. Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
Yamada K; Kubo K; Shuto K; Nakamizo N
Jpn J Pharmacol; 1984 Nov; 36(3):283-90. PubMed ID: 6521073
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy enhances the pressor response to thromboxane analogues in rabbits.
Losonczy G; Singh JP; Schoenl M; Mucha I; Venuto RC
Am J Physiol; 1995 Sep; 269(3 Pt 2):R720-5. PubMed ID: 7573575
[TBL] [Abstract][Full Text] [Related]
17. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart.
Purchase M; Dusting GJ; Li DM; Read MA
Circ Res; 1986 Jan; 58(1):172-6. PubMed ID: 3080260
[TBL] [Abstract][Full Text] [Related]
18. Experimental ischemic heart disease induced by thromboxane A2 in rabbits.
Morooka S; Kobayashi M; Shimamoto T
Jpn Circ J; 1977 Dec; 41(12):1373-9. PubMed ID: 606849
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
20. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
Gorman RR; Wierenga W; Miller OV
Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
